Combined HIV Adolescent Prevention Study (CHAPS)

Webb, E

(2022). Combined HIV Adolescent Prevention Study (CHAPS). [Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. 10.17037/DATA.00002891.

Copy

CHAPS was a a mixed-methods study amongst young people aged 13–24 years. The first component consists of qualitative research to identify the barriers and motivators towards the uptake of PrEP amongst young people in South Africa, Uganda and Zimbabwe. The second component is a randomised clinical trial (ClinicalTrials.gov NCT03986970) using a novel ex vivo HIV challenge method to investigate the optimal PrEP treatment (FTC-TDF vs FTC-TAF), dose and schedule.

Item Type	Collection
Project start and completion date	From To 2017 2022
Funder	European and Developing Countries Clinical Trials Partnership
Date	13 May 2022
Project contact	Webb, Emily
Associated roles	Fox, Julie
LSHTM Faculty/Department	Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology (-2023)
Participating Institutions	London School of Hygiene & Tropical Medicine, London, United Kingdom; King's College London, London, United Kingdom; University of the Witwatersrand, Johannesburg, South Africa; University of Cape Town, Cape Town, South Africa, Harare, Zimbabwe; University of Zimbabwe, Harare, Zimbabwe; Imperial College London, London, United Kingdom; University of Liverpool, Liverpool, United Kingdom; Karolinska Institutet, Solna, Sweden; Desmond Tutu HIV Foundation, Cape Town, South Africa; University of Washington, Seattle, Washington, United States of America
Relationships	Combined HIV Adolescent Prevention Study (CHAPS): qualitative survey data